,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,1.99984327242173e-05,0.0164387116993066
2,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.000364372071718928,0.119324584552919
3,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.000435491184499703,0.119324584552919
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.00127378399005139,0.163819021219669
5,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.00135594725702427,0.163819021219669
6,WP_BENZENE_METABOLISM,3,Up,0.00136337587816022,0.163819021219669
7,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00148007181874299,0.163819021219669
8,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.0017882375554675,0.163819021219669
9,WP_ZINC_HOMEOSTASIS,21,Up,0.00179363891846353,0.163819021219669
10,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,33,Down,0.00249266315135467,0.176537831883353
11,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.00256364420661758,0.176537831883353
12,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.00287089941000844,0.176537831883353
13,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.00291154629154821,0.176537831883353
14,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,25,Down,0.00300672706370674,0.176537831883353
15,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.00360651275339514,0.197636898886054
16,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.00549249352891604,0.282176855048061
17,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.00731426387818613,0.311732503597581
18,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.00732721956824815,0.311732503597581
19,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.00733337512096935,0.311732503597581
20,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0075847324476297,0.311732503597581
21,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.0085658168053861,0.335290543525113
22,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.0104775252920703,0.378874531577884
23,WP_IL26_SIGNALING,31,Down,0.0106011121974347,0.378874531577884
24,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0126541636456135,0.396492838107802
25,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0137993665946255,0.396492838107802
26,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.0147412366534304,0.396492838107802
27,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.0148733108956379,0.396492838107802
28,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.0159896483005877,0.396492838107802
29,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.0163281069534137,0.396492838107802
30,WP_NEUROINFLAMMATION,10,Down,0.0163649530236575,0.396492838107802
31,WP_TOLLLIKE_RECEPTOR_SIGNALING,77,Down,0.0166181121080801,0.396492838107802
32,WP_CREATINE_PATHWAY,2,Down,0.0168585247026095,0.396492838107802
33,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.01745334584996,0.396492838107802
34,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.0175843746401667,0.396492838107802
35,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Down,0.0177348570268021,0.396492838107802
36,WP_CHOLESTEROL_METABOLISM,52,Down,0.0178153744232575,0.396492838107802
37,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.0179665836824514,0.396492838107802
38,WP_ERBB_SIGNALING,67,Down,0.018329352613256,0.396492838107802
39,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0194224679682718,0.396898701134487
40,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,86,Down,0.019826480134978,0.396898701134487
41,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.021144489724754,0.396898701134487
42,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.0211501424652672,0.396898701134487
43,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.0212979828865056,0.396898701134487
44,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.0216368723671592,0.396898701134487
45,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0217280310840048,0.396898701134487
46,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,11,Up,0.0237341034724202,0.415744076075265
47,WP_DOPAMINE_METABOLISM,7,Up,0.0239325885672306,0.415744076075265
48,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0251820244554074,0.415744076075265
49,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0254523632982137,0.415744076075265
50,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.0259408968332889,0.415744076075265
51,WP_LEPTIN_SIGNALING,69,Down,0.026923034233131,0.415744076075265
52,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.0279640538183599,0.415744076075265
53,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.0285802499203986,0.415744076075265
54,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.0287371372007178,0.415744076075265
55,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,26,Down,0.0287513063959232,0.415744076075265
56,WP_RANKLRANK_SIGNALING,47,Down,0.0288183488260803,0.415744076075265
57,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.0293325448370151,0.415744076075265
58,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.0295977068306531,0.415744076075265
59,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0303089948292535,0.415744076075265
60,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.0303776187288309,0.415744076075265
61,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.0312321610710115,0.415744076075265
62,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.0325261216225007,0.415744076075265
63,WP_IRINOTECAN_PATHWAY,5,Up,0.0325533353158301,0.415744076075265
64,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.0343279505682526,0.415744076075265
65,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,69,Down,0.0345833331464485,0.415744076075265
66,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.0348520865136351,0.415744076075265
67,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Down,0.0353408282074297,0.415744076075265
68,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.0355697407856396,0.415744076075265
69,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0356200614859712,0.415744076075265
70,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.0360625648854928,0.415744076075265
71,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0360680481462198,0.415744076075265
72,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.037589355838703,0.415744076075265
73,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.0378566983568141,0.415744076075265
74,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.0380128878986857,0.415744076075265
75,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.0380772798720009,0.415744076075265
76,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0388785949654905,0.415744076075265
77,WP_ATR_SIGNALING,10,Up,0.0389443964206757,0.415744076075265
78,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Up,0.0407297990904131,0.427245724587219
79,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.0415431250941005,0.427245724587219
80,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.0415810924172476,0.427245724587219
81,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.0422870419736911,0.429135166695977
82,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.04413877924431,0.439055188159918
83,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.0443328231353688,0.439055188159918
84,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0458130219850158,0.445383565155877
85,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.046055478148722,0.445383565155877
86,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0486561813574425,0.465062570649043
87,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0504933574200871,0.469935877690728
88,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.0514463034852899,0.469935877690728
89,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Down,0.0515232834993287,0.469935877690728
90,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.0517909570499954,0.469935877690728
91,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.0520245314718446,0.469935877690728
92,WP_NRF2_PATHWAY,67,Up,0.0531461056278407,0.474848900283533
93,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.0544003560032536,0.476100227304203
94,WP_MONOAMINE_TRANSPORT,11,Down,0.0544445515408699,0.476100227304203
95,WP_ALLOGRAFT_REJECTION,48,Down,0.0559093768623806,0.483763239798704
96,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.0574467044910136,0.485271714704009
97,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.0579502617114124,0.485271714704009
98,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.0583451199053878,0.485271714704009
99,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Down,0.0586464356970417,0.485271714704009
100,WP_ENDOCHONDRAL_OSSIFICATION,25,Up,0.0596258432908819,0.485271714704009
101,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,25,Up,0.0596258432908819,0.485271714704009
102,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.061592895980831,0.496366279374932
103,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.063048465954497,0.49845638569938
104,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.0636533921606708,0.49845638569938
105,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,24,Up,0.0636714361294829,0.49845638569938
106,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.0653758347003702,0.504956549939439
107,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0657303538242335,0.504956549939439
108,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.0672869540573166,0.512128483658465
109,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.0686595154976099,0.517780933385645
110,WP_TYPE_II_DIABETES_MELLITUS,13,Down,0.0697099427801186,0.517820407387576
111,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0708864266771868,0.517820407387576
112,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.071121685310149,0.517820407387576
113,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.0719253768810487,0.517820407387576
114,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.0719799181863803,0.517820407387576
115,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.0724444608875562,0.517820407387576
116,WP_TRANSLATION_FACTORS,49,Down,0.0733853224088417,0.520023577759206
117,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.0741508925638055,0.520957552884172
118,WP_MAPK_CASCADE,30,Down,0.0754390734272919,0.525516257264694
119,WP_CELL_CYCLE,89,Up,0.0778081672291316,0.535536047771895
120,WP_ESTROGEN_SIGNALING,21,Down,0.0781804449302037,0.535536047771895
121,WP_AEROBIC_GLYCOLYSIS,10,Up,0.0814696373123686,0.537019961763509
122,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.0814696373123686,0.537019961763509
123,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.081618089900665,0.537019961763509
124,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0823034596612001,0.537019961763509
125,WP_GLUCURONIDATION,7,Up,0.0830509464648133,0.537019961763509
126,WP_ENDOMETRIAL_CANCER,48,Down,0.0836980505412862,0.537019961763509
127,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0837136581209954,0.537019961763509
128,WP_IL5_SIGNALING,37,Down,0.0838928564361908,0.537019961763509
129,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Down,0.0843017146306961,0.537019961763509
130,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.084930164269168,0.537019961763509
131,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Up,0.0873028912085809,0.542192701809666
132,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.087987410581911,0.542192701809666
133,WP_OSTEOBLAST_SIGNALING,2,Down,0.088144120833243,0.542192701809666
134,WP_NETRINUNC5B_SIGNALING,35,Down,0.0895178314491251,0.542192701809666
135,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0902832490987181,0.542192701809666
136,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.0903097664337366,0.542192701809666
137,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0906482777336932,0.542192701809666
138,WP_SMALL_LIGAND_GPCRS,7,Up,0.09102505212863,0.542192701809666
139,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Down,0.0967467841440204,0.561440616405708
140,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.097880135723178,0.561440616405708
141,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.0980045317470135,0.561440616405708
142,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.0982257242139907,0.561440616405708
143,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.0983545605382262,0.561440616405708
144,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.0983545605382262,0.561440616405708
145,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.0992189596779929,0.562468861071105
146,WP_PURINE_METABOLISM,9,Down,0.103070170089351,0.576789657779373
147,WP_CHEMOKINE_SIGNALING,107,Down,0.104145375076253,0.576789657779373
148,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.104153477788285,0.576789657779373
149,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.104551896604777,0.576789657779373
150,WP_MTHFR_DEFICIENCY,18,Up,0.106747127357315,0.58275925026598
151,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.10708589667812,0.58275925026598
152,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.107760834599062,0.58275925026598
153,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Down,0.108673895498197,0.583671368208211
154,WP_DNA_DAMAGE_RESPONSE,57,Up,0.110470754395152,0.583671368208211
155,WP_GLUCOCORTICOID_BIOSYNTHESIS,5,Up,0.111000595120099,0.583671368208211
156,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.113087518695446,0.583671368208211
157,WP_IL1_SIGNALING,51,Down,0.113495632099145,0.583671368208211
158,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.116143751481305,0.583671368208211
159,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.116227491522282,0.583671368208211
160,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.116539232299389,0.583671368208211
161,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.116902855629977,0.583671368208211
162,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.117052871170624,0.583671368208211
163,WP_NRF2ARE_REGULATION,20,Up,0.117114954669562,0.583671368208211
164,WP_PHOSPHOINOSITIDES_METABOLISM,37,Down,0.117295907187391,0.583671368208211
165,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.117653715887498,0.583671368208211
166,WP_CAMKK2_PATHWAY,29,Up,0.117930386094313,0.583671368208211
167,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.11858043612016,0.583671368208211
168,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Up,0.122888182530965,0.584874128330749
169,WP_INSULIN_SIGNALING,129,Down,0.122941073129208,0.584874128330749
170,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.123632743085629,0.584874128330749
171,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.123656998409408,0.584874128330749
172,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.123808080853718,0.584874128330749
173,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.124828644628119,0.584874128330749
174,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.125693288385702,0.584874128330749
175,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Up,0.126029733427016,0.584874128330749
176,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.12622781983887,0.584874128330749
177,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Down,0.126606623154969,0.584874128330749
178,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.126651575234639,0.584874128330749
179,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.12859324472309,0.588767436490885
180,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.129483301358473,0.588767436490885
181,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.129643437962105,0.588767436490885
182,WP_MEVALONATE_PATHWAY,7,Down,0.130474957909214,0.589287996710844
183,WP_G1_TO_S_CELL_CYCLE_CONTROL,48,Up,0.131791153144426,0.591979933796274
184,WP_KIT_RECEPTOR_SIGNALING,50,Down,0.134283211950173,0.599895653386101
185,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.136434248064822,0.601232505113975
186,WP_VITAMIN_B12_METABOLISM,23,Down,0.136463396670103,0.601232505113975
187,WP_ACUTE_MYELOID_LEUKEMIA,54,Down,0.137180211263441,0.601232505113975
188,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.137508164186651,0.601232505113975
189,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.140849480501131,0.604539191081454
190,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.141757509148803,0.604539191081454
191,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.143054080530276,0.604539191081454
192,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.145116909845292,0.604539191081454
193,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.145353074718697,0.604539191081454
194,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.145447385799738,0.604539191081454
195,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.145447385799738,0.604539191081454
196,WP_VITAMIN_D_RECEPTOR_PATHWAY,80,Down,0.14555249853739,0.604539191081454
197,WP_B_CELL_RECEPTOR_SIGNALING,83,Down,0.145573551493691,0.604539191081454
198,WP_GLYOXYLATE_METABOLISM,5,Up,0.145618929238598,0.604539191081454
199,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.147736414190085,0.610247901830403
200,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.150488707123705,0.618508586278428
201,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.151750312557736,0.619102498362082
202,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Up,0.152139543393115,0.619102498362082
203,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,38,Up,0.153963656459189,0.623140246285439
204,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.154647944333613,0.623140246285439
205,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.156250697422269,0.626527186737098
206,WP_ALPHA_6_BETA_4_SIGNALING,25,Down,0.159854550980314,0.629091755867613
207,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.160292394141852,0.629091755867613
208,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.160733399032315,0.629091755867613
209,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.161345003662322,0.629091755867613
210,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.161554753411759,0.629091755867613
211,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.161888262588619,0.629091755867613
212,WP_NPHP1_DELETION_SYNDROME,10,Down,0.163046795265769,0.629091755867613
213,WP_MACROPHAGE_MARKERS,8,Down,0.163253387386849,0.629091755867613
214,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.164566477004091,0.629091755867613
215,WP_GASTRIC_CANCER_NETWORK_2,24,Down,0.164874947989934,0.629091755867613
216,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.165648164268392,0.629091755867613
217,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.166074101001547,0.629091755867613
218,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.166882736762248,0.629255089993432
219,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.168927875709661,0.633903231549718
220,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.16998279183563,0.633903231549718
221,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.170428971012759,0.633903231549718
222,WP_SMALL_CELL_LUNG_CANCER,66,Down,0.171389833109197,0.634605598269188
223,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.174956171985734,0.64309104932983
224,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.175870424280586,0.64309104932983
225,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.176943012705512,0.64309104932983
226,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.177342444499086,0.64309104932983
227,WP_CILIARY_LANDSCAPE,183,Up,0.177593270313712,0.64309104932983
228,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.178756334558768,0.644463627225034
229,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.180150987529133,0.646655509820731
230,WP_JOUBERT_SYNDROME,70,Up,0.181994336880984,0.647738661715636
231,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.182239291796528,0.647738661715636
232,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.183576874430211,0.647738661715636
233,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,10,Up,0.183604754476573,0.647738661715636
234,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,6,Down,0.185050098281472,0.649084490652088
235,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.18568712519246,0.649084490652088
236,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.186355157900113,0.649084490652088
237,WP_MINERALOCORTICOID_BIOSYNTHESIS,4,Up,0.18898372186104,0.655462528986392
238,WP_GPR40_PATHWAY,7,Down,0.190580205949999,0.655865524277669
239,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.190695693798495,0.655865524277669
240,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.193791400223675,0.661619272753245
241,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.194921340722518,0.661619272753245
242,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.19558817917158,0.661619272753245
243,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.19558817917158,0.661619272753245
244,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,54,Down,0.1996635266764,0.672636962819677
245,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.202443833851295,0.679219720105162
246,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.203358478716134,0.67951491668562
247,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.207777138013875,0.690675917917209
248,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.209400721978122,0.690675917917209
249,WP_MELANOMA,52,Down,0.209459601104008,0.690675917917209
250,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.210059585741244,0.690675917917209
251,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.211712491182529,0.690728486768848
252,WP_MONOAMINE_GPCRS,3,Up,0.212702413781938,0.690728486768848
253,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,169,Down,0.214151591392724,0.690728486768848
254,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.214188457058466,0.690728486768848
255,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.214277085311504,0.690728486768848
256,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.217095927111146,0.693980460670539
257,WP_THERMOGENESIS,72,Down,0.217243206386886,0.693980460670539
258,WP_NGLYCAN_BIOSYNTHESIS,51,Up,0.218460845934216,0.693980460670539
259,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.218662943203977,0.693980460670539
260,WP_GASTRIN_SIGNALING,92,Down,0.220694602102747,0.697089133795241
261,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.22133852058462,0.697089133795241
262,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.222706378484969,0.698720011887956
263,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.225023532221538,0.699970755766243
264,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.225202032245094,0.699970755766243
265,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.226200310302998,0.699970755766243
266,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.226511217802702,0.699970755766243
267,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.229621042921647,0.701818687428034
268,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.230039180288529,0.701818687428034
269,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,20,Down,0.230194231715415,0.701818687428034
270,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.230524386381471,0.701818687428034
271,WP_SYNAPTIC_VESICLE_PATHWAY,19,Up,0.23189005800946,0.702549005463026
272,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.232630252707268,0.702549005463026
273,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.233328319332611,0.702549005463026
274,WP_SILDENAFIL_TREATMENT,10,Down,0.238756177140093,0.716268531420279
275,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.241286841565496,0.717090958373102
276,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.241525226246223,0.717090958373102
277,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Down,0.241647439743734,0.717090958373102
278,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.243078064560032,0.718741615353763
279,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.244930067957428,0.721070390495905
280,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.245620084353836,0.721070390495905
281,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.247134546724838,0.722934510348102
282,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.251573735093992,0.731278421349252
283,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.252633499390085,0.731278421349252
284,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.252668665052584,0.731278421349252
285,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.253750503336273,0.731278421349252
286,WP_OSTEOPONTIN_SIGNALING,10,Down,0.254534848665918,0.731278421349252
287,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.255404939395248,0.731278421349252
288,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.256214337407037,0.731278421349252
289,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.260630892105884,0.741310011456873
290,WP_PPAR_SIGNALING,39,Down,0.264459473936645,0.748700621968974
291,WP_HEART_DEVELOPMENT,16,Up,0.265614592980825,0.748700621968974
292,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.266229892033501,0.748700621968974
293,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.267650680247283,0.748700621968974
294,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.267783434134889,0.748700621968974
295,WP_RETINOL_METABOLISM,6,Down,0.269625301194133,0.750540244608981
296,WP_IL18_SIGNALING,185,Down,0.270267533338514,0.750540244608981
297,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.271898286393752,0.752526570423112
298,WP_CORI_CYCLE,11,Up,0.27747198036813,0.760672962566548
299,WP_FOCAL_ADHESION,113,Down,0.277923897745591,0.760672962566548
300,WP_HYPERTROPHY_MODEL,12,Down,0.278911042664573,0.760672962566548
301,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.279609816214261,0.760672962566548
302,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.281575718884821,0.760672962566548
303,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.281726612280102,0.760672962566548
304,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.282834302425834,0.760672962566548
305,WP_TGFBETA_RECEPTOR_SIGNALING,33,Down,0.283054684150531,0.760672962566548
306,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.283170226940832,0.760672962566548
307,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.286606452663959,0.762218206344353
308,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Down,0.287632170921707,0.762218206344353
309,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.287757336470928,0.762218206344353
310,WP_COPPER_HOMEOSTASIS,39,Up,0.288052711104004,0.762218206344353
311,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.28843753925995,0.762218206344353
312,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Up,0.291360277508158,0.762218206344353
313,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.291552392722093,0.762218206344353
314,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.292839506480432,0.762218206344353
315,WP_GLIOBLASTOMA_SIGNALING,65,Down,0.29289799237273,0.762218206344353
316,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.293018191246734,0.762218206344353
317,WP_TYPE_II_INTERFERON_SIGNALING,29,Up,0.29406367148778,0.762524725435188
318,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.296591204571843,0.76590086560342
319,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.29722916803831,0.76590086560342
320,WP_SERINE_METABOLISM,5,Down,0.30022228770906,0.771196001552648
321,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.301813944868748,0.772869354149878
322,WP_IL17_SIGNALING,25,Down,0.304141386323758,0.775850319488279
323,WP_KLEEFSTRA_SYNDROME,24,Down,0.304865758144421,0.775850319488279
324,WP_ASPIRIN_AND_MIRNAS,8,Down,0.306316413438216,0.776291818754808
325,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.307064643239721,0.776291818754808
326,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.307872424469668,0.776291818754808
327,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.309617298584481,0.778304034973832
328,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.311402926311919,0.780406114110967
329,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.313634623538063,0.783609910481117
330,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.315479492509899,0.784106690572058
331,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.318253213268124,0.784106690572058
332,WP_NOTCH_SIGNALING_WP268,34,Up,0.319984547666936,0.784106690572058
333,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.320042691595894,0.784106690572058
334,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.322197883052362,0.784106690572058
335,WP_PROLACTIN_SIGNALING,68,Down,0.322464871350297,0.784106690572058
336,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.32306728388345,0.784106690572058
337,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.323642563081183,0.784106690572058
338,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.323959301439268,0.784106690572058
339,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.324145189998728,0.784106690572058
340,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.325157145945669,0.784106690572058
341,WP_TAR_SYNDROME,43,Down,0.32531550921966,0.784106690572058
342,WP_FOLATE_METABOLISM,36,Down,0.32623417052998,0.784106690572058
343,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Up,0.328472122373715,0.78628977278292
344,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.329055574011344,0.78628977278292
345,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,162,Down,0.331609544511482,0.790095784314313
346,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.338037430970292,0.802576120786453
347,WP_TRYPTOPHAN_METABOLISM,18,Up,0.341000194578555,0.802576120786453
348,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,124,Up,0.341308346299153,0.802576120786453
349,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.342095728447735,0.802576120786453
350,WP_ADIPOGENESIS,84,Up,0.344379697986536,0.802576120786453
351,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.345758779860236,0.802576120786453
352,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,60,Up,0.346713755547592,0.802576120786453
353,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,59,Up,0.347362524946908,0.802576120786453
354,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,16,Down,0.3476294101168,0.802576120786453
355,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.348401606518563,0.802576120786453
356,WP_IRON_METABOLISM_DISORDERS,10,Up,0.348562590957756,0.802576120786453
357,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.348921920698798,0.802576120786453
358,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.349540451632056,0.802576120786453
359,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.351880662523123,0.803644806166673
360,WP_AXON_GUIDANCE,35,Up,0.351961228978105,0.803644806166673
361,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.354251360782174,0.806633292418137
362,WP_CYTOSINE_METHYLATION,7,Up,0.357161040333685,0.811012086061572
363,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.358176972590606,0.811078433800216
364,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.36175066340491,0.814923448380442
365,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.362773047487476,0.814923448380442
366,WP_LUNG_FIBROSIS,29,Down,0.362918139282807,0.814923448380442
367,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.36412128376786,0.814923448380442
368,WP_APOPTOSIS_MODULATION_AND_SIGNALING,75,Down,0.364831908763993,0.814923448380442
369,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.367280224531696,0.81816895546085
370,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.370875344942015,0.823944685249557
371,WP_IL4_SIGNALING,50,Down,0.372871512507191,0.826146585662833
372,WP_GASTRIC_CANCER_NETWORK_1,15,Up,0.374704292675004,0.826426890463373
373,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.375008795794207,0.826426890463373
374,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.377373732714007,0.829414995430251
375,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.378479939393813,0.829628027151238
376,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Up,0.37989597759158,0.830517270160317
377,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.382567516038055,0.834139252475546
378,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.386673412691969,0.839503241185199
379,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.387197923601684,0.839503241185199
380,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,59,Down,0.388091522689022,0.839503241185199
381,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.391941025266178,0.844212090550098
382,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.392322407043963,0.844212090550098
383,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.396333710565628,0.850616997610825
384,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.401564774352697,0.858957498444176
385,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.402309777251834,0.858957498444176
386,WP_GPCRS_OTHER,11,Down,0.403645380831893,0.859576432755999
387,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.407781788201246,0.861633081895225
388,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.408934189012285,0.861633081895225
389,WP_NAD_METABOLISM,11,Down,0.410224280563844,0.861633081895225
390,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.410233054564085,0.861633081895225
391,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.413707303150549,0.861633081895225
392,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.414180860607845,0.861633081895225
393,WP_IDO_METABOLIC_PATHWAY,7,Down,0.414321403946529,0.861633081895225
394,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.415599207454487,0.861633081895225
395,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,89,Up,0.416153258636008,0.861633081895225
396,WP_NEOVASCULARIZATION_PROCESSES,20,Down,0.417157236979449,0.861633081895225
397,WP_KALLMANN_SYNDROME,11,Down,0.41734009302014,0.861633081895225
398,WP_ARYLAMINE_METABOLISM,1,Up,0.419444078725146,0.861633081895225
399,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.420316910841783,0.861633081895225
400,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Down,0.421483836414544,0.861633081895225
401,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.421784734401379,0.861633081895225
402,WP_HEME_BIOSYNTHESIS,8,Up,0.421784734401379,0.861633081895225
403,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.42547240790872,0.861633081895225
404,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.426064992826547,0.861633081895225
405,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.42739107838493,0.861633081895225
406,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.427820581775214,0.861633081895225
407,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.429562951822458,0.861633081895225
408,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.429657026579175,0.861633081895225
409,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.430407068203969,0.861633081895225
410,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.430884242155554,0.861633081895225
411,WP_ONECARBON_METABOLISM,22,Up,0.431712592679447,0.861633081895225
412,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.431864756375709,0.861633081895225
413,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.435155118549698,0.866095659680029
414,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.436310329380795,0.866297320654621
415,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,45,Down,0.437383317163315,0.866335148694566
416,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.439669186548076,0.868569673489782
417,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.441702743624532,0.868569673489782
418,WP_KININKALLIKREIN_PATHWAY,2,Up,0.44266196805896,0.868569673489782
419,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.442955666889879,0.868569673489782
420,WP_SLEEP_REGULATION,10,Down,0.445703807624927,0.868569673489782
421,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Down,0.446127651722733,0.868569673489782
422,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,0.448211161010492,0.868569673489782
423,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Down,0.448329464644813,0.868569673489782
424,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.448524778630567,0.868569673489782
425,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Down,0.449937031097596,0.868569673489782
426,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.450134648304924,0.868569673489782
427,WP_TP53_NETWORK,16,Down,0.457185926986553,0.878152359692345
428,WP_NEURAL_CREST_DIFFERENTIATION,37,Up,0.458877331085969,0.878152359692345
429,WP_BASE_EXCISION_REPAIR,29,Up,0.459329253483586,0.878152359692345
430,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.45971040543185,0.878152359692345
431,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.460442417308273,0.878152359692345
432,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.462841077528447,0.879412458872434
433,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.46339267914437,0.879412458872434
434,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,45,Up,0.464312660767198,0.879412458872434
435,WP_NOTCH_SIGNALING_WP61,48,Down,0.46712924032324,0.879523146054558
436,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.467217958422823,0.879523146054558
437,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.467581039934114,0.879523146054558
438,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.469526379701212,0.881165945466659
439,WP_AUTOPHAGY,27,Down,0.470739250237199,0.88142975784733
440,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.472862631939151,0.883393371486323
441,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.4756275740374,0.885166078087268
442,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.4794122548624,0.885166078087268
443,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.480998928140092,0.885166078087268
444,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.48253323817175,0.885166078087268
445,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.483155030534836,0.885166078087268
446,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.483452251154982,0.885166078087268
447,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.483606436285559,0.885166078087268
448,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.48447253628138,0.885166078087268
449,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.484488183921712,0.885166078087268
450,WP_FOXA2_PATHWAY,9,Down,0.486632135008588,0.885166078087268
451,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.486737330353214,0.885166078087268
452,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.486949854061135,0.885166078087268
453,WP_OSTEOCLAST_SIGNALING,7,Down,0.491611044000141,0.885166078087268
454,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.492231921359344,0.885166078087268
455,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.493001937403541,0.885166078087268
456,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.493026494628169,0.885166078087268
457,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.493971760351921,0.885166078087268
458,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.494316014895858,0.885166078087268
459,WP_PPARALPHA_PATHWAY,15,Up,0.495924907638473,0.885166078087268
460,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.496422978616263,0.885166078087268
461,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Down,0.497807216348033,0.885166078087268
462,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.497830853603557,0.885166078087268
463,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Up,0.49857894665986,0.885166078087268
464,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.501133373685388,0.886497421250907
465,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.501962802971809,0.886497421250907
466,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.502564231512072,0.886497421250907
467,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,88,Up,0.503905814833443,0.886606229769521
468,WP_IL7_SIGNALING,23,Down,0.504839492173979,0.886606229769521
469,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.506233555013123,0.886606229769521
470,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.506940301693035,0.886606229769521
471,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.50914653678554,0.888574210695783
472,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.513223599229818,0.893088440930016
473,WP_NUCLEOTIDE_GPCRS,5,Down,0.514857325099378,0.893088440930016
474,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.515839900682423,0.893088440930016
475,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,6,Down,0.516159632194664,0.893088440930016
476,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.51716556920035,0.893088440930016
477,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.519158939748693,0.893934061558781
478,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.519966396002861,0.893934061558781
479,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.520917780397392,0.893934061558781
480,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.524553449776706,0.898297782742608
481,WP_P38_MAPK_SIGNALING,31,Up,0.529365702442004,0.903053168816041
482,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Up,0.529731827766037,0.903053168816041
483,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.531375089661809,0.903053168816041
484,WP_MATRIX_METALLOPROTEINASES,8,Up,0.531724736869786,0.903053168816041
485,WP_HEPATITIS_B_INFECTION,116,Down,0.533151722107045,0.903609722828847
486,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.537490729838815,0.907302656482578
487,WP_INFLAMMATORY_RESPONSE_PATHWAY,12,Down,0.53833722061266,0.907302656482578
488,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.539662272336898,0.907302656482578
489,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.53974574090022,0.907302656482578
490,WP_PLEURAL_MESOTHELIOMA,244,Down,0.542391871000299,0.909464984325783
491,WP_PROSTAGLANDIN_SIGNALING,20,Down,0.543456983971002,0.909464984325783
492,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.545812668723567,0.909464984325783
493,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.550369681109292,0.909464984325783
494,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.551046456803403,0.909464984325783
495,WP_COMPLEMENT_SYSTEM,46,Up,0.551335101814455,0.909464984325783
496,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,70,Down,0.55297569275175,0.909464984325783
497,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.55381275737158,0.909464984325783
498,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.554909469955986,0.909464984325783
499,WP_MEASLES_VIRUS_INFECTION,98,Up,0.555663376995433,0.909464984325783
500,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.555694600327323,0.909464984325783
501,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Up,0.558096426106102,0.909464984325783
502,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.559199850920778,0.909464984325783
503,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.560799497152966,0.909464984325783
504,WP_DRAVET_SYNDROME,12,Down,0.561109312644479,0.909464984325783
505,WP_DNA_REPLICATION,35,Up,0.562502547770152,0.909464984325783
506,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.56353157870995,0.909464984325783
507,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.564259733748237,0.909464984325783
508,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.565660705737186,0.909464984325783
509,WP_ATM_SIGNALING,34,Up,0.567112336252644,0.909464984325783
510,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.567830272801862,0.909464984325783
511,WP_SPINAL_CORD_INJURY,63,Down,0.56985627226486,0.909464984325783
512,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.56994023206829,0.909464984325783
513,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Up,0.570256656328307,0.909464984325783
514,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.570338033151576,0.909464984325783
515,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.572258343307552,0.909464984325783
516,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.573281561700291,0.909464984325783
517,WP_CCL18_SIGNALING,20,Down,0.573555604986121,0.909464984325783
518,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.575580234885366,0.909464984325783
519,WP_MALE_INFERTILITY,65,Down,0.576173558762991,0.909464984325783
520,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.578036223096675,0.909464984325783
521,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.579255563817389,0.909464984325783
522,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.581062663685227,0.909464984325783
523,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.581181677827362,0.909464984325783
524,WP_NRXN1_DELETION_SYNDROME,2,Down,0.582447307190914,0.909464984325783
525,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.584507753642494,0.909464984325783
526,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.585364271498126,0.909464984325783
527,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.585588914277602,0.909464984325783
528,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.587963707892432,0.909464984325783
529,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.588003005833045,0.909464984325783
530,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.588112078393598,0.909464984325783
531,WP_PURINERGIC_SIGNALING,14,Down,0.588411339852646,0.909464984325783
532,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.588607508103791,0.909464984325783
533,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.591930421115739,0.912883313615642
534,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.595240569460993,0.914916635811097
535,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.595474939366104,0.914916635811097
536,WP_IL3_SIGNALING,46,Down,0.597037945562926,0.915606700098369
537,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Up,0.598411521292799,0.916004228124173
538,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Up,0.603160082823242,0.9208437317711
539,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.603813590540904,0.9208437317711
540,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.60884014787772,0.923800287318406
541,WP_INTEGRATED_CANCER_PATHWAY,38,Down,0.608840607780816,0.923800287318406
542,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.609123790421625,0.923800287318406
543,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.612217006724446,0.924777849114307
544,WP_ALZHEIMERS_DISEASE,182,Down,0.614813332849532,0.924777849114307
545,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,182,Down,0.614813332849532,0.924777849114307
546,WP_EICOSANOID_SYNTHESIS,13,Up,0.616781740423077,0.924777849114307
547,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.616986536799498,0.924777849114307
548,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.617096856719405,0.924777849114307
549,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.617643599955906,0.924777849114307
550,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.619815973246966,0.925916677474074
551,WP_AGERAGE_PATHWAY,54,Down,0.621846067894614,0.925916677474074
552,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.624354657580509,0.925916677474074
553,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.627210541751296,0.925916677474074
554,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.62763737555644,0.925916677474074
555,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.629569424118098,0.925916677474074
556,WP_ENERGY_METABOLISM,41,Down,0.634134142511619,0.925916677474074
557,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Up,0.634580150034816,0.925916677474074
558,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.635017812221107,0.925916677474074
559,WP_NEPHROTIC_SYNDROME,27,Up,0.635385535718282,0.925916677474074
560,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.635857214365406,0.925916677474074
561,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.636490084802368,0.925916677474074
562,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.636550322999922,0.925916677474074
563,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.637290149193353,0.925916677474074
564,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.637414058466306,0.925916677474074
565,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.637825010259257,0.925916677474074
566,WP_TNFALPHA_SIGNALING,82,Down,0.638346206837064,0.925916677474074
567,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.638679751980292,0.925916677474074
568,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.640250177956749,0.926458369169095
569,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.642153051085248,0.926458369169095
570,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Up,0.644148691941496,0.926458369169095
571,WP_CHOLESTASIS,9,Down,0.644780282917472,0.926458369169095
572,WP_MIRNA_BIOGENESIS,6,Up,0.646729506755053,0.926458369169095
573,WP_WNT_SIGNALING_WP363,36,Up,0.647093497036189,0.926458369169095
574,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.647492458292727,0.926458369169095
575,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.64807002709517,0.926458369169095
576,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.650982764891708,0.929006654064208
577,WP_VALPROIC_ACID_PATHWAY,8,Down,0.652625456360036,0.929736785317071
578,WP_IL9_SIGNALING,15,Down,0.655981491237515,0.931336864300949
579,WP_ANGIOGENESIS,12,Down,0.656014652591544,0.931336864300949
580,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.659528307962869,0.934710808871515
581,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Down,0.661792193104395,0.934786511938732
582,WP_GLUTATHIONE_METABOLISM,10,Up,0.661856143489467,0.934786511938732
583,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.666073412540975,0.935679290275329
584,WP_IL2_SIGNALING,37,Down,0.666077521090097,0.935679290275329
585,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Down,0.66643160617283,0.935679290275329
586,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.667041440512582,0.935679290275329
587,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.670894607896612,0.939481035248747
588,WP_BURN_WOUND_HEALING,59,Down,0.672306484172636,0.939857023792358
589,WP_MAPK_SIGNALING,156,Down,0.674128058073802,0.940803503797395
590,WP_IL19_SIGNALING,20,Up,0.677739994686978,0.942541669319092
591,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.678610162413012,0.942541669319092
592,WP_TAMOXIFEN_METABOLISM,2,Up,0.68232959310922,0.942541669319092
593,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.68240442811289,0.942541669319092
594,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.682872683840006,0.942541669319092
595,WP_BLADDER_CANCER,28,Down,0.682967155117236,0.942541669319092
596,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.683568962028271,0.942541669319092
597,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.684546686841238,0.942541669319092
598,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.687247078233923,0.944240026287523
599,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.68921704775292,0.944240026287523
600,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.690186908920629,0.944240026287523
601,WP_ALSTROM_SYNDROME,27,Up,0.690495972531547,0.944240026287523
602,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Up,0.69152371754877,0.944240026287523
603,WP_PREIMPLANTATION_EMBRYO,20,Down,0.693663352472029,0.945590838693214
604,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.695874097272712,0.947033953573128
605,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.698286821605502,0.948746722908633
606,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.699639703418277,0.948820990044664
607,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.701245833567658,0.948820990044664
608,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.701804333269046,0.948820990044664
609,WP_ECTODERM_DIFFERENTIATION,74,Up,0.705918827198507,0.949100980670085
610,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.706380065323916,0.949100980670085
611,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.706735726682505,0.949100980670085
612,WP_PDGFRBETA_PATHWAY,27,Down,0.707923339269626,0.949100980670085
613,WP_ENDOTHELIN_PATHWAYS,12,Up,0.71003368098743,0.949100980670085
614,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.713048109720785,0.949100980670085
615,WP_COMPLEMENT_ACTIVATION,11,Up,0.713342567002834,0.949100980670085
616,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.713735902809193,0.949100980670085
617,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.713877883123498,0.949100980670085
618,WP_MRNA_PROCESSING,124,Up,0.714413686582598,0.949100980670085
619,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.714712295662752,0.949100980670085
620,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.715965420004586,0.949231572973823
621,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.718207750843171,0.950306207538543
622,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.720237582289979,0.950306207538543
623,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.720244242453178,0.950306207538543
624,WP_RETT_SYNDROME,31,Down,0.723720426885411,0.952123514741204
625,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.724950155225568,0.952123514741204
626,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.726279515169046,0.952123514741204
627,WP_BREAST_CANCER_PATHWAY,83,Down,0.727003244185441,0.952123514741204
628,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.727413098853377,0.952123514741204
629,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.730479621076633,0.953675870686224
630,WP_TGFB_SMAD_SIGNALING,7,Up,0.731111216795734,0.953675870686224
631,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.733266579922146,0.953675870686224
632,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.73525930153505,0.953675870686224
633,WP_SPHINGOLIPID_PATHWAY,20,Up,0.735689933675196,0.953675870686224
634,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.736206745987765,0.953675870686224
635,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.737713469166357,0.953675870686224
636,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.738076261377793,0.953675870686224
637,WP_ENDODERM_DIFFERENTIATION,79,Up,0.739040790300638,0.953675870686224
638,WP_CILIOPATHIES,123,Up,0.741453057643065,0.955289049189027
639,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.742954816731523,0.955725914480927
640,WP_DNA_MISMATCH_REPAIR,21,Up,0.744749886354183,0.956538135286154
641,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.746310498477536,0.957047160294126
642,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.747681701722334,0.957274368656924
643,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.748817499244131,0.957274368656924
644,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.749981378850436,0.957274368656924
645,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,77,Down,0.753145986995724,0.958183052447826
646,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.754623792854453,0.958183052447826
647,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.754780147679519,0.958183052447826
648,WP_PYRIMIDINE_METABOLISM,71,Down,0.755355982951571,0.958183052447826
649,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.760198714369249,0.958857485470895
650,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,19,Up,0.760543469897129,0.958857485470895
651,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.761351218851157,0.958857485470895
652,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.762428219515847,0.958857485470895
653,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.764081213248831,0.958857485470895
654,WP_BDNFTRKB_SIGNALING,26,Up,0.765224042350316,0.958857485470895
655,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.769434467456534,0.958857485470895
656,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.770239248318622,0.958857485470895
657,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.770756586964236,0.958857485470895
658,WP_PDGF_PATHWAY,35,Down,0.773557388629307,0.958857485470895
659,WP_FOXP3_IN_COVID19,9,Down,0.773896506418781,0.958857485470895
660,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.776734522765041,0.958857485470895
661,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.780583056852168,0.958857485470895
662,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.780742800144527,0.958857485470895
663,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Down,0.780894098729749,0.958857485470895
664,WP_NEPHROGENESIS,4,Up,0.781101351636821,0.958857485470895
665,WP_WNT_SIGNALING_WP428,57,Up,0.785887808283376,0.958857485470895
666,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.787291422193157,0.958857485470895
667,WP_FERROPTOSIS,50,Up,0.790336084253137,0.958857485470895
668,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.79072647074368,0.958857485470895
669,WP_HISTONE_MODIFICATIONS,36,Up,0.791696829602273,0.958857485470895
670,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.792070177557594,0.958857485470895
671,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Up,0.79268269948755,0.958857485470895
672,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.794173255393074,0.958857485470895
673,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.794253428697114,0.958857485470895
674,WP_CANCER_PATHWAYS,293,Up,0.79473590854109,0.958857485470895
675,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.797106359004814,0.958857485470895
676,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.800052826712428,0.958857485470895
677,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.801369119743384,0.958857485470895
678,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.802358706578254,0.958857485470895
679,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,38,Down,0.802832900852298,0.958857485470895
680,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.802905860659255,0.958857485470895
681,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.804099022811041,0.958857485470895
682,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.805107123266675,0.958857485470895
683,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.806870353632339,0.958857485470895
684,WP_EGFEGFR_SIGNALING,136,Up,0.807088394944417,0.958857485470895
685,WP_BARDETBIEDL_SYNDROME,65,Up,0.807860323431407,0.958857485470895
686,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.809996080410336,0.958857485470895
687,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.810757985453789,0.958857485470895
688,WP_G13_SIGNALING,29,Down,0.811364291387733,0.958857485470895
689,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.812036185773786,0.958857485470895
690,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.813423743154905,0.958857485470895
691,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.813692830133319,0.958857485470895
692,WP_HIPPOYAP_SIGNALING,16,Up,0.813896012490612,0.958857485470895
693,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.815847369546001,0.958857485470895
694,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.816796462908846,0.958857485470895
695,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.816806869343395,0.958857485470895
696,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.818212913765046,0.958857485470895
697,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.820776382260516,0.958857485470895
698,WP_PEPTIDE_GPCRS,13,Up,0.821588300255708,0.958857485470895
699,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.821797787917224,0.958857485470895
700,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.821908518782166,0.958857485470895
701,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.823560005603531,0.958857485470895
702,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.82774508204363,0.958857485470895
703,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.828475756354096,0.958857485470895
704,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.828712494223678,0.958857485470895
705,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.830014293986484,0.958857485470895
706,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.830826679192283,0.958857485470895
707,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.83171612404692,0.958857485470895
708,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.83402385461892,0.958857485470895
709,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.834117961738892,0.958857485470895
710,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.835473168762955,0.958857485470895
711,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Up,0.835859793068537,0.958857485470895
712,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.836345404506153,0.958857485470895
713,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.83641702987814,0.958857485470895
714,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.836510885133454,0.958857485470895
715,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.836586244285889,0.958857485470895
716,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.837128732260997,0.958857485470895
717,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.839016390980262,0.958857485470895
718,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.839893944399166,0.958857485470895
719,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,56,Down,0.840152201400347,0.958857485470895
720,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.840439111344932,0.958857485470895
721,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.841041663046855,0.958857485470895
722,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.843766317253499,0.959390466289805
723,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.843843439327894,0.959390466289805
724,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.849813965608075,0.964820014396549
725,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.851053095369161,0.964820014396549
726,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.852140304686003,0.964820014396549
727,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.856641806227719,0.965718931321914
728,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.856990589252523,0.965718931321914
729,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.856990589252523,0.965718931321914
730,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.859396151756318,0.965718931321914
731,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.861506972680578,0.965718931321914
732,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.861554413195671,0.965718931321914
733,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Up,0.861583593129777,0.965718931321914
734,WP_OVARIAN_INFERTILITY,20,Down,0.862332963005212,0.965718931321914
735,WP_AMINO_ACID_METABOLISM,58,Down,0.86397184846627,0.966237903999013
736,WP_METHYLATION_PATHWAYS,5,Up,0.868317480043958,0.968753273377813
737,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.869254081977364,0.968753273377813
738,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.870213607737793,0.968753273377813
739,WP_SEROTONIN_AND_ANXIETY,7,Down,0.872204833266299,0.968753273377813
740,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.873284452548038,0.968753273377813
741,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.873292184395328,0.968753273377813
742,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.875317056482618,0.969524039444454
743,WP_G_PROTEIN_SIGNALING,61,Down,0.876345938329963,0.969524039444454
744,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.881292018776716,0.970312296306958
745,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.881998638206947,0.970312296306958
746,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.882961230366521,0.970312296306958
747,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.883375261886513,0.970312296306958
748,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.884134873285071,0.970312296306958
749,WP_VITAMIN_B12_DISORDERS,9,Down,0.88414100965196,0.970312296306958
750,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.885386675493655,0.970383796341046
751,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.890060060429787,0.972077784816578
752,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Down,0.890474920790933,0.972077784816578
753,WP_PI3KAKT_SIGNALING,172,Down,0.891280546474208,0.972077784816578
754,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.891662590938808,0.972077784816578
755,WP_CELLULAR_PROTEOSTASIS,6,Down,0.899392842117914,0.978983354830726
756,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.900378851888113,0.978983354830726
757,WP_PRION_DISEASE_PATHWAY,28,Down,0.903308142505521,0.980870928850116
758,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,43,Down,0.905488308341813,0.981249972850739
759,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Up,0.907725734541052,0.981249972850739
760,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.908627738360458,0.981249972850739
761,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.90906118343057,0.981249972850739
762,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Down,0.909932230653207,0.981249972850739
763,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.910819622001355,0.981249972850739
764,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Up,0.913274936602801,0.982150077422888
765,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.915849131659334,0.982150077422888
766,WP_STEROID_BIOSYNTHESIS,2,Up,0.916075305257108,0.982150077422888
767,WP_IL11_SIGNALING,40,Up,0.916434439639118,0.982150077422888
768,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.919767097737121,0.983646985702775
769,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.920224491490795,0.983646985702775
770,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,55,Down,0.924775056241752,0.984348449967338
771,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.925217378237658,0.984348449967338
772,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.925357075092227,0.984348449967338
773,WP_FRAGILE_X_SYNDROME,83,Up,0.926569810991155,0.984348449967338
774,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.926868248509392,0.984348449967338
775,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.928072410849539,0.984355511894608
776,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.930706772615217,0.984670478817962
777,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.932416386254775,0.984670478817962
778,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.933111707701389,0.984670478817962
779,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.933265174371474,0.984670478817962
780,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.934358848513394,0.984670478817962
781,WP_HIPPO_SIGNALING_REGULATION,43,Down,0.93648597327137,0.985648489153734
782,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.941432430921278,0.986173919420641
783,WP_IL6_SIGNALING,38,Down,0.941531172849889,0.986173919420641
784,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.945270001187427,0.986173919420641
785,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.9533651106876,0.986173919420641
786,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.954082871381551,0.986173919420641
787,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.954464212558863,0.986173919420641
788,WP_SPINA_BIFIDA,10,Down,0.954616871833593,0.986173919420641
789,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.957047394680399,0.986173919420641
790,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.957325473061564,0.986173919420641
791,WP_VEGFAVEGFR2_SIGNALING,333,Up,0.95775361750761,0.986173919420641
792,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Up,0.958309076656012,0.986173919420641
793,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Down,0.95831742242876,0.986173919420641
794,WP_NUCLEAR_RECEPTORS,20,Up,0.959176366925492,0.986173919420641
795,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.959992076121946,0.986173919420641
796,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.960254190463812,0.986173919420641
797,WP_TRANSSULFURATION_PATHWAY,8,Down,0.960277662114641,0.986173919420641
798,WP_KREBS_CYCLE_DISORDERS,11,Up,0.961318896306751,0.986173919420641
799,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.962786671499471,0.986173919420641
800,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.963296027174219,0.986173919420641
801,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.964243017698487,0.986173919420641
802,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.964572463659426,0.986173919420641
803,WP_PROTEASOME_DEGRADATION,57,Down,0.964773286916275,0.986173919420641
804,WP_RAS_SIGNALING,113,Up,0.96545490416614,0.986173919420641
805,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.965778595053061,0.986173919420641
806,WP_APOPTOSIS,70,Down,0.968353941592127,0.987576848621252
807,WP_HUNGER_AND_SATIETY,2,Up,0.974915767986918,0.992426524233387
808,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.978038809555524,0.992426524233387
809,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.979953905031656,0.992426524233387
810,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.981230768289975,0.992426524233387
811,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,130,Down,0.981410317252073,0.992426524233387
812,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.982594415845219,0.992426524233387
813,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.982651899922425,0.992426524233387
814,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.982767871929413,0.992426524233387
815,WP_ID_SIGNALING,12,Down,0.987926699322857,0.99466772304292
816,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.989133658885679,0.99466772304292
817,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.989441239302322,0.99466772304292
818,WP_VITAMIN_D_METABOLISM,6,Down,0.990013939334565,0.99466772304292
819,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Up,0.991037548871231,0.99466772304292
820,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.994096186112632,0.996473425039259
821,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.995261170264272,0.996473425039259
822,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.996988600262802,0.996988600262802
